Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Itacitinib Study for Treatment-Naïve Acute Graft-Versus-Host Disease Does Not Meet Primary Endpoint

americanpharmaceuticalreviewJanuary 06, 2020

Tag: Itacitinib , Incyte , GRAVITAS-301 , GVHD

PharmaSources Customer Service